Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-004108
Filing Date
2023-09-29
Accepted
2023-09-29 11:05:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4713
  Complete submission text file 0001959173-23-004108.txt   6071
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39712 | Film No.: 231292898
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Harmon Cyrus (Reporting) CIK: 0001831410 (see all company filings)

Type: 144